Literature DB >> 23520991

World Health Organization regional assessments of the risks of poliovirus outbreaks.

Sara A Lowther1, Sigrun Roesel, Patrick O'Connor, Mauricio Landaverde, George Oblapenko, Sergei Deshevoi, Goel Ajay, Ann Buff, Hala Safwat, Mbaye Salla, Rudi Tangermann, Nino Khetsuriani, Rebecca Martin, Steven Wassilak.   

Abstract

While global polio eradication requires tremendous efforts in countries where wild polioviruses (WPVs) circulate, numerous outbreaks have occurred following WPV importation into previously polio-free countries. Countries that have interrupted endemic WPV transmission should continue to conduct routine risk assessments and implement mitigation activities to maintain their polio-free status as long as wild poliovirus circulates anywhere in the world. This article reviews the methods used by World Health Organization (WHO) regional offices to qualitatively assess risk of WPV outbreaks following an importation. We describe the strengths and weaknesses of various risk assessment approaches, and opportunities to harmonize approaches. These qualitative assessments broadly categorize risk as high, medium, or low using available national information related to susceptibility, the ability to rapidly detect WPV, and other population or program factors that influence transmission, which the regions characterize using polio vaccination coverage, surveillance data, and other indicators (e.g., sanitation), respectively. Data quality and adequacy represent a challenge in all regions. WHO regions differ with respect to the methods, processes, cut-off values, and weighting used, which limits comparisons of risk assessment results among regions. Ongoing evaluation of indicators within regions and further harmonization of methods between regions are needed to effectively plan risk mitigation activities in a setting of finite resources for funding and continued WPV circulation.
© 2013 Society for Risk Analysis.

Entities:  

Mesh:

Year:  2013        PMID: 23520991     DOI: 10.1111/risa.12032

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  13 in total

1.  Immunity to polio, measles and rubella in women of child-bearing age and estimated congenital rubella syndrome incidence, Cambodia, 2012.

Authors:  B Mao; K Chheng; K Wannemuehler; E Vynnycky; S Buth; S C Soeung; S Reef; W Weldon; L Quick; C J Gregory
Journal:  Epidemiol Infect       Date:  2014-11-06       Impact factor: 4.434

2.  Predictive spatial risk model of poliovirus to aid prioritization and hasten eradication in Nigeria.

Authors:  Alexander M Upfill-Brown; Hil M Lyons; Muhammad A Pate; Faisal Shuaib; Shahzad Baig; Hao Hu; Philip A Eckhoff; Guillaume Chabot-Couture
Journal:  BMC Med       Date:  2014-06-04       Impact factor: 8.775

3.  Measuring polio immunity to plan immunization activities.

Authors:  Arend Voorman; Hil M Lyons
Journal:  Vaccine       Date:  2016-10-19       Impact factor: 3.641

4.  An assessment of the geographical risks of wild and vaccine-derived poliomyelitis outbreaks in Africa and Asia.

Authors:  Kathleen M O'Reilly; Christine Lamoureux; Natalie A Molodecky; Hil Lyons; Nicholas C Grassly; Graham Tallis
Journal:  BMC Infect Dis       Date:  2017-05-26       Impact factor: 3.090

5.  Expansion of Vaccination Services and Strengthening Vaccine-Preventable Diseases Surveillance in Haiti, 2010-2016.

Authors:  Rania A Tohme; Jeannot Francois; Kathleen F Cavallaro; Gilson Paluku; Idrissa Yalcouye; Ernsley Jackson; Tracie Wright; Paul Adrien; Mark A Katz; Terri B Hyde; Pape Faye; Francine Kimanuka; Vance Dietz; John Vertefeuille; David Lowrance; Benjamin Dahl; Roopal Patel
Journal:  Am J Trop Med Hyg       Date:  2017-10       Impact factor: 2.345

6.  Assessing the risks for poliovirus outbreaks in polio-free countries--Africa, 2012-2013.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-09-20       Impact factor: 17.586

7.  The potential impact of expanding target age groups for polio immunization campaigns.

Authors:  Radboud J Duintjer Tebbens; Dominika A Kalkowska; Steven G F Wassilak; Mark A Pallansch; Stephen L Cochi; Kimberly M Thompson
Journal:  BMC Infect Dis       Date:  2014-01-29       Impact factor: 3.090

8.  Analysis of vaccination campaign effectiveness and population immunity to support and sustain polio elimination in Nigeria.

Authors:  Alexander M Upfill-Brown; Arend Voorman; Guillaume Chabot-Couture; Faisal Shuaib; Hil M Lyons
Journal:  BMC Med       Date:  2016-03-30       Impact factor: 8.775

9.  High Incidence of Mammalian Orthoreovirus Identified by Environmental Surveillance in Taiwan.

Authors:  Matthew C Y Lim; Ya-Fang Wang; Sheng-Wen Huang; Jyh-Yuan Yang; Jen-Ren Wang
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

10.  Spatial model for risk prediction and sub-national prioritization to aid poliovirus eradication in Pakistan.

Authors:  Laina D Mercer; Rana M Safdar; Jamal Ahmed; Abdirahman Mahamud; M Muzaffar Khan; Sue Gerber; Aiden O'Leary; Mike Ryan; Frank Salet; Steve J Kroiss; Hil Lyons; Alexander Upfill-Brown; Guillaume Chabot-Couture
Journal:  BMC Med       Date:  2017-10-11       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.